Quantifying the heterogeneity of enzymatic dePEGyaltion of liposomal nanocarrier systems

Rasmus Eliasen, Thomas Lars Andresen*, Jannik Bruun Larsen*

*Corresponding author for this work

Research output: Contribution to journalJournal articleResearchpeer-review

75 Downloads (Pure)

Abstract

Lipid nanoparticles have been clinically successful in particular recently within the vaccine field, but better tools are needed to analyze heterogeneities at the single particle level to progress drug delivery designs to the next level. Especially, liposomal nanocarriers are becoming increasingly complex e.g. by employing environmental cues for shedding their protective PEG layer, however a detailed mechanistic understanding of how the dePEGylation varies from liposome-to-liposome is still missing. Here we present the development of a fluorescence microscopy based assay capable of detecting the enzyme mediated dePEGylation of individual liposomes. We employ this methodology to understand how enzyme type-, concentration- and incubation time, in addition to liposome size, affects the dePEGylation at the single particle level.
Original languageEnglish
JournalEuropean Journal of Pharmaceutics and Biopharmaceutics
Volume171
Pages (from-to)80-89
ISSN0939-6411
DOIs
Publication statusPublished - 2022

Keywords

  • Liposomal nanocarriers
  • Enzyme mediated dePEGylation
  • Single liposome measurements
  • Quantitative flourescence microscopy
  • Liposome heterogeneity

Fingerprint

Dive into the research topics of 'Quantifying the heterogeneity of enzymatic dePEGyaltion of liposomal nanocarrier systems'. Together they form a unique fingerprint.

Cite this